{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T17:06:22Z","timestamp":1794848782312,"version":"4.9.1"},"reference-count":114,"publisher":"Elsevier","isbn-type":[{"value":"9780443472169","type":"print"}],"license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100014824","name":"Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, India","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014824","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026]]},"DOI":"10.1016\/bs.irn.2026.07.003","type":"book-chapter","created":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T11:18:48Z","timestamp":1785237528000},"page":"27-59","source":"Crossref","is-referenced-by-count":0,"title":["Blood biomarkers of oxidative stress and mitochondrial dysfunction in Parkinson\u2019s disease and Alzheimer\u2019s disease"],"prefix":"10.1016","author":[{"given":"Deepak","family":"Kumar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Snehasish","family":"Shee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashok Kumar","family":"Datusalia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shyam Sunder","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/bs.irn.2026.07.003_bib1","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.2174\/1567205014666170203141151","article-title":"Commonalities in biological pathways, genetics, and cellular mechanism between Alzheimer disease and other neurodegenerative diseases: An in silico-updated overview","volume":"14","author":"Ahmad","year":"2017","journal-title":"Current Alzheimer Research"},{"key":"10.1016\/bs.irn.2026.07.003_bib2","doi-asserted-by":"crossref","first-page":"110817","DOI":"10.1016\/j.clinbiochem.2024.110817","article-title":"Deteriorated thiol-disulphide and oxidized-reduced glutathione status in blood in Alzheimer\u2019s disease","volume":"133\u2013134","author":"Akunal","year":"2024","journal-title":"Clinical Biochemistry"},{"issue":"8","key":"10.1016\/bs.irn.2026.07.003_bib3","doi-asserted-by":"crossref","first-page":"2567","DOI":"10.1038\/s41591-025-03833-1","article-title":"Shared and disease-specific pathways in frontotemporal dementia and Alzheimer\u2019s and Parkinson\u2019s diseases","volume":"31","author":"Ali","year":"2025","journal-title":"Nature Medicine"},{"issue":"1","key":"10.1016\/bs.irn.2026.07.003_bib4","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s11033-025-10463-w","article-title":"Molecular mechanisms and biomarkers in neurodegenerative disorders: A comprehensive review","volume":"52","author":"Ali","year":"2025","journal-title":"Molecular Biology Reports"},{"issue":"7","key":"10.1016\/bs.irn.2026.07.003_bib5","doi-asserted-by":"crossref","first-page":"4346","DOI":"10.1039\/D1RA06437A","article-title":"Sensitive immunosensing of \u03b1-synuclein protein in human plasma samples using gold nanoparticles conjugated with graphene: An innovative immuno-platform towards early stage identification of Parkinson\u2019s disease using point of care (POC) analysis","volume":"12","author":"Aminabad","year":"2022","journal-title":"RSC Advances"},{"key":"10.1016\/bs.irn.2026.07.003_bib6","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.brainresbull.2017.03.009","article-title":"Metabolic dysfunction in Parkinson\u2019s disease: Bioenergetics, redox homeostasis and central carbon metabolism","volume":"133","author":"Anandhan","year":"2017","journal-title":"Brain Research Bulletin"},{"issue":"22","key":"10.1016\/bs.irn.2026.07.003_bib7","doi-asserted-by":"crossref","first-page":"12379","DOI":"10.3390\/ijms252212379","article-title":"Parkinson\u2019s disease: Biomarkers for diagnosis and disease progression","volume":"25","author":"Arya","year":"2024","journal-title":"International Journal of Molecular Sciences"},{"issue":"16","key":"10.1016\/bs.irn.2026.07.003_bib8","doi-asserted-by":"crossref","first-page":"8689","DOI":"10.3390\/ijms22168689","article-title":"Glutathione and related molecules in parkinsonism","volume":"22","author":"Asanuma","year":"2021","journal-title":"International Journal of Molecular Sciences"},{"issue":"8","key":"10.1016\/bs.irn.2026.07.003_bib9","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.3390\/cells11081279","article-title":"Mass spectrometry for neurobiomarker discovery: The relevance of post-translational modifications","volume":"11","author":"Azevedo","year":"2022","journal-title":"Cells"},{"issue":"3","key":"10.1016\/bs.irn.2026.07.003_bib10","doi-asserted-by":"crossref","first-page":"527","DOI":"10.3390\/medicina61030527","article-title":"Evaluating heart rate variability as a biomarker for autonomic function in Parkinson\u2019s disease rehabilitation: A clustering-based analysis of exercise-induced changes","volume":"61","author":"Basri","year":"2025","journal-title":"Medicina"},{"issue":"3","key":"10.1016\/bs.irn.2026.07.003_bib11","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1002\/alz.12745","article-title":"Amyloid\u2010beta misfolding and GFAP predict risk of clinical Alzheimer\u2019s disease diagnosis within 17 years","volume":"19","author":"Beyer","year":"2023","journal-title":"Alzheimer\u2019s & Dementia"},{"issue":"1","key":"10.1016\/bs.irn.2026.07.003_bib12","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s00441-018-2817-y","article-title":"Genetic risk factors in Parkinson\u2019s disease","volume":"373","author":"Billingsley","year":"2018","journal-title":"Cell and Tissue Research"},{"issue":"9","key":"10.1016\/bs.irn.2026.07.003_bib13","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/s00415-025-13325-4","article-title":"CSF phospho-tau levels at Parkinson\u2019s disease onset predict the risk for development of motor complications","volume":"272","author":"Bissacco","year":"2025","journal-title":"Journal of Neurology"},{"key":"10.1016\/bs.irn.2026.07.003_bib14","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.neubiorev.2020.10.004","article-title":"The glutathione system in Parkinson\u2019s disease and its progression","volume":"120","author":"Bj\u00f8rklund","year":"2021","journal-title":"Neuroscience & Biobehavioral Reviews"},{"issue":"10","key":"10.1016\/bs.irn.2026.07.003_bib15","doi-asserted-by":"crossref","first-page":"3041","DOI":"10.1093\/brain\/awaa246","article-title":"Mitochondrial damage-associated inflammation highlights biomarkers in PRKN\/PINK1 parkinsonism","volume":"143","author":"Borsche","year":"2020","journal-title":"Brain"},{"key":"10.1016\/bs.irn.2026.07.003_bib16","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/bs.acc.2024.06.005","article-title":"Digital biomarkers in Parkinson\u2019s disease","volume":"123","author":"Bougea","year":"2024","journal-title":"Advances in Clinical Chemistry"},{"issue":"3","key":"10.1016\/bs.irn.2026.07.003_bib17","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.cmet.2022.02.001","article-title":"The NADPARK study: A randomized phase I trial of nicotinamide riboside supplementation in Parkinson\u2019s disease","volume":"34","author":"Brakedal","year":"2022","journal-title":"Cell Metabolism"},{"issue":"3","key":"10.1016\/bs.irn.2026.07.003_bib18","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/s41583-019-0132-6","article-title":"Oxidative stress, dysfunctional glucose metabolism and Alzheimer disease","volume":"20","author":"Butterfield","year":"2019","journal-title":"Nature Reviews Neuroscience"},{"key":"10.1016\/bs.irn.2026.07.003_bib19","doi-asserted-by":"crossref","first-page":"902","DOI":"10.3389\/fphar.2019.00902","article-title":"Mitochondria as potential targets in Alzheimer disease therapy: An update","volume":"10","author":"Cenini","year":"2019","journal-title":"Frontiers in Pharmacology"},{"issue":"1","key":"10.1016\/bs.irn.2026.07.003_bib20","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/s41531-023-00564-3","article-title":"Parkinson\u2019s disease neurons exhibit alterations in mitochondrial quality control proteins","volume":"9","author":"Chen","year":"2023","journal-title":"Npj Parkinson\u2019s Disease"},{"issue":"1","key":"10.1016\/bs.irn.2026.07.003_bib21","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s13195-022-00961-5","article-title":"Altered central and blood glutathione in Alzheimer\u2019s disease and mild cognitive impairment: A meta-analysis","volume":"14","author":"Chen","year":"2022","journal-title":"Alzheimer\u2019s Research & Therapy"},{"key":"10.1016\/bs.irn.2026.07.003_bib22","doi-asserted-by":"crossref","first-page":"163","DOI":"10.3389\/fnins.2018.00163","article-title":"The association of tau with mitochondrial dysfunction in Alzheimer\u2019s disease","volume":"12","author":"Cheng","year":"2018","journal-title":"Frontiers in Neuroscience"},{"issue":"3","key":"10.1016\/bs.irn.2026.07.003_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.ahr.2025.100240","article-title":"Commercially available products for the digital tracking of biomarkers in Parkinson\u2019s disease","volume":"5","author":"Cronin","year":"2025","journal-title":"Aging and Health Research"},{"key":"10.1016\/bs.irn.2026.07.003_bib24","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.neuro.2024.02.005","article-title":"Neuronal exosomal miRNAs modulate mitochondrial functions and cell death in bystander neuronal cells under Parkinson\u2019s disease stress conditions","volume":"101","author":"Currim","year":"2024","journal-title":"Neurotoxicology"},{"issue":"2","key":"10.1016\/bs.irn.2026.07.003_bib25","article-title":"Cerebrospinal fluid biomarkers for diagnosis of Parkinson\u2019s disease: A systematic review","volume":"17","author":"Dasari","year":"2025","journal-title":"Cureus"},{"issue":"5","key":"10.1016\/bs.irn.2026.07.003_bib26","doi-asserted-by":"crossref","first-page":"993","DOI":"10.3390\/cells10050993","article-title":"Neuronal and astrocytic extracellular vesicle biomarkers in blood reflect brain pathology in mouse models of Alzheimer\u2019s disease","volume":"10","author":"Delgado-Peraza","year":"2021","journal-title":"Cells"},{"key":"10.1016\/bs.irn.2026.07.003_bib27","doi-asserted-by":"crossref","DOI":"10.3389\/fbinf.2025.1513790","article-title":"Urinary based biomarkers identification and genetic profiling in Parkinson\u2019s disease: A systematic review of metabolomic studies","volume":"5","author":"Dhiman","year":"2025","journal-title":"Frontiers in Bioinformatics"},{"issue":"16","key":"10.1016\/bs.irn.2026.07.003_bib28","doi-asserted-by":"crossref","first-page":"7792","DOI":"10.3390\/ijms26167792","article-title":"Reliable new biomarkers of mitochondrial oxidative stress and neuroinflammation in cerebrospinal fluid and plasma from Alzheimer\u2019s disease patients: A pilot study","volume":"26","author":"Di Lorenzo","year":"2025","journal-title":"International Journal of Molecular Sciences"},{"key":"10.1016\/bs.irn.2026.07.003_bib29","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2025.1579511","article-title":"Comparative analysis of neuroinflammatory pathways in Alzheimer\u2019s disease, Parkinson\u2019s disease, and multiple sclerosis: Insights into similarities and distinctions","volume":"19","author":"Doroszkiewicz","year":"2025","journal-title":"Frontiers in Neuroscience"},{"issue":"1","key":"10.1016\/bs.irn.2026.07.003_bib30","doi-asserted-by":"crossref","first-page":"133","DOI":"10.20517\/evcna.2023.13","article-title":"Synaptic proteins in neuron-derived extracellular vesicles as biomarkers for Alzheimer\u2019s disease: Novel methodology and clinical proof of concept","volume":"4","author":"Eitan","year":"2023","journal-title":"Extracellular Vesicles and Circulating Nucleic Acids"},{"issue":"4","key":"10.1016\/bs.irn.2026.07.003_bib31","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1002\/ana.24335","article-title":"Polygenic risk of Parkinson disease is correlated with disease age at onset","volume":"77","author":"Escott-Price","year":"2015","journal-title":"Annals of Neurology"},{"key":"10.1016\/bs.irn.2026.07.003_bib32","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.nicl.2013.06.004","article-title":"Multiclass classification of FDG PET scans for the distinction between Parkinson\u2019s disease and atypical parkinsonian syndromes","volume":"2","author":"Garraux","year":"2013","journal-title":"NeuroImage: Clinical"},{"key":"10.1016\/bs.irn.2026.07.003_bib33","doi-asserted-by":"crossref","DOI":"10.3389\/fncir.2023.1099467","article-title":"Aberrant protein S-nitrosylation contributes to hyperexcitability-induced synaptic damage in Alzheimer\u2019s disease: Mechanistic insights and potential therapies","volume":"17","author":"Ghatak","year":"2023","journal-title":"Frontiers in Neural Circuits"},{"key":"10.1016\/bs.irn.2026.07.003_bib34","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2021.734976","article-title":"MicroRNAs as factors in bidirectional crosstalk between mitochondria and the nucleus during cellular senescence","volume":"12","author":"Giordani","year":"2021","journal-title":"Frontiers in Physiology"},{"issue":"6","key":"10.1016\/bs.irn.2026.07.003_bib35","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1007\/s11011-021-00735-2","article-title":"Emerging urinary alpha-synuclein and miRNA biomarkers in Parkinson\u2019s disease","volume":"37","author":"Giri","year":"2022","journal-title":"Metabolic Brain Disease"},{"issue":"7324","key":"10.1016\/bs.irn.2026.07.003_bib36","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1038\/nature09536","article-title":"Oxidant stress evoked by pacemaking in dopaminergic neurons is attenuated by DJ-1","volume":"468","author":"Guzman","year":"2010","journal-title":"Nature"},{"issue":"11","key":"10.1016\/bs.irn.2026.07.003_bib37","doi-asserted-by":"crossref","first-page":"8928","DOI":"10.1007\/s12035-024-04128-1","article-title":"Unraveling dysregulated cell signaling pathways, genetic and epigenetic mysteries of Parkinson\u2019s disease","volume":"61","author":"Hamidpour","year":"2024","journal-title":"Molecular Neurobiology"},{"issue":"13","key":"10.1016\/bs.irn.2026.07.003_bib38","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1002\/1873-3468.14895","article-title":"Neuronal glutathione depletion elevates the A\u03b242\/A\u03b240 ratio and tau aggregation in Alzheimer\u2019s disease mice","volume":"598","author":"Hashim","year":"2024","journal-title":"FEBS Letters"},{"key":"10.1016\/bs.irn.2026.07.003_bib39","first-page":"1","article-title":"Regulatory, translational, and operational considerations for the incorporation of biomarkers in drug development","author":"Hatcher","year":"2025","journal-title":"Therapeutic Innovation & Regulatory Science"},{"issue":"2","key":"10.1016\/bs.irn.2026.07.003_bib40","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1021\/acschemneuro.8b00288","article-title":"Alpha-synuclein nitration and its implications in Parkinson\u2019s disease","volume":"10","author":"He","year":"2018","journal-title":"ACS Chemical Neuroscience"},{"key":"10.1016\/bs.irn.2026.07.003_bib41","first-page":"1","article-title":"Gut microbiota and microRNAs as biomarkers in Parkinson\u2019s disease: Early identification, diagnostic and potential treatments","author":"Hern\u00e1ndez-Garc\u00eda","year":"2025","journal-title":"Molecular and Cellular Biochemistry"},{"issue":"4","key":"10.1016\/bs.irn.2026.07.003_bib42","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0282684","article-title":"In vivo detection of substantia nigra and locus coeruleus volume loss in Parkinson\u2019s disease using neuromelanin-sensitive MRI: Replication in two cohorts","volume":"18","author":"Hwang","year":"2023","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/bs.irn.2026.07.003_bib43","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.201708734","article-title":"miR\u2010181a\/b downregulation exerts a protective action on mitochondrial disease models","volume":"11","author":"Indrieri","year":"2019","journal-title":"EMBO Molecular Medicine"},{"issue":"7","key":"10.1016\/bs.irn.2026.07.003_bib44","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1136\/jnnp-2019-322588","article-title":"Serum neuronal exosomes predict and differentiate Parkinson\u2019s disease from atypical parkinsonism","volume":"91","author":"Jiang","year":"2020","journal-title":"Journal of Neurology, Neurosurgery & Psychiatry"},{"issue":"3","key":"10.1016\/bs.irn.2026.07.003_bib45","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1002\/mds.30098","article-title":"Mitochondrial DNA copy number as a potential biomarker for the severity of motor symptoms and prognosis in Parkinson\u2019s disease","volume":"40","author":"Jo","year":"2025","journal-title":"Movement Disorders"},{"issue":"2","key":"10.1016\/bs.irn.2026.07.003_bib46","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s11011-025-01552-7","article-title":"Unraveling the role of Nrf2 in dopaminergic neurons: A review of oxidative stress and mitochondrial dysfunction in Parkinson\u2019s disease","volume":"40","author":"Kaur","year":"2025","journal-title":"Metabolic Brain Disease"},{"issue":"5","key":"10.1016\/bs.irn.2026.07.003_bib47","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s40336-020-00386-w","article-title":"Dopamine transporter imaging in neurodegenerative movement disorders: PET vs","volume":"8","author":"Kerstens","year":"2020","journal-title":"SPECT. Clinical and Translational Imaging"},{"issue":"3","key":"10.1016\/bs.irn.2026.07.003_bib48","first-page":"137","article-title":"Oxidative stress-related biomarkers in Parkinson\u2019s disease: A systematic review and meta-analysis","volume":"17","author":"Khan","year":"2018","journal-title":"Iranian Journal of Neurology"},{"key":"10.1016\/bs.irn.2026.07.003_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.cca.2024.120001","article-title":"Electrochemical biosensors in early detection of Parkinson disease","volume":"565","author":"Khatami","year":"2025","journal-title":"Clinica Chimica Acta"},{"key":"10.1016\/bs.irn.2026.07.003_bib50","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2020.581882","article-title":"Mitochondrial RNA in Alzheimer\u2019s disease circulating extracellular vesicles","volume":"8","author":"Kim","year":"2020","journal-title":"Frontiers in Cell and Developmental Biology"},{"issue":"12","key":"10.1016\/bs.irn.2026.07.003_bib51","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.3390\/antiox13121462","article-title":"Role of oxidative stress in blood\u2013brain barrier disruption and neurodegenerative diseases","volume":"13","author":"Kim","year":"2024","journal-title":"Antioxidants"},{"issue":"7","key":"10.1016\/bs.irn.2026.07.003_bib52","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.3390\/biomedicines10071760","article-title":"Biomarkers of neurodegenerative diseases: Biology, taxonomy, clinical relevance, and current research status","volume":"10","author":"Kon\u00ed\u010dkov\u00e1","year":"2022","journal-title":"Biomedicines"},{"issue":"5","key":"10.1016\/bs.irn.2026.07.003_bib53","doi-asserted-by":"crossref","first-page":"811","DOI":"10.3233\/JPD-230007","article-title":"Serum uric acid as a putative biomarker in prodromal Parkinson\u2019s disease: Longitudinal data from the PPMI study","volume":"13","author":"Koros","year":"2023","journal-title":"Journal of Parkinson\u2019s Disease"},{"key":"10.1016\/bs.irn.2026.07.003_bib54","first-page":"23","article-title":"Gut microbiota-based interventions for Parkinson\u2019s disease: Neuroprotective mechanisms and current perspective","volume":"1","author":"Kumar","year":"2025","journal-title":"Probiotics and Antimicrobial Proteins"},{"key":"10.1016\/bs.irn.2026.07.003_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainres.2025.149540","article-title":"Treadmill exercise mitigates rotenone-induced neuroinflammation and \u03b1-synuclein level in a mouse model of Parkinson\u2019s disease","volume":"1854","author":"Kumar","year":"2025","journal-title":"Brain Research"},{"issue":"1","key":"10.1016\/bs.irn.2026.07.003_bib56","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/s41531-024-00842-8","article-title":"Mitochondrial oxidant stress promotes \u03b1-synuclein aggregation and spreading in mice with mutated glucocerebrosidase","volume":"10","author":"La Vitola","year":"2024","journal-title":"Npj Parkinson\u2019s Disease"},{"issue":"01","key":"10.1016\/bs.irn.2026.07.003_bib57","doi-asserted-by":"crossref","first-page":"22","DOI":"10.65457\/JNMMI-2025-0012","article-title":"Diagnostic value of dopamine transporter imaging with SPECT and PET in differentiating Parkinson\u2019s disease from atypical parkinsonian syndromes: A systematic review and meta-analysis","volume":"1","author":"Li","year":"2025","journal-title":"Journal of Nuclear Medicine and Molecular Imaging"},{"issue":"1","key":"10.1016\/bs.irn.2026.07.003_bib58","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s40035-024-00432-x","article-title":"Updates in Alzheimer\u2019s disease: From basic research to diagnosis and therapies","volume":"13","author":"Liu","year":"2024","journal-title":"Translational Neurodegeneration"},{"key":"10.1016\/bs.irn.2026.07.003_bib59","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuroimage.2024.120943","article-title":"Relaxometry network based on MRI R2* mapping revealing brain iron accumulation patterns in Parkinson\u2019s disease","volume":"303","author":"Lu","year":"2024","journal-title":"NeuroImage"},{"issue":"4","key":"10.1016\/bs.irn.2026.07.003_bib60","first-page":"1813","article-title":"Biomarkers of Parkinson\u2019s disease: From basic research to clinical practice","volume":"15","author":"Ma","year":"2024","journal-title":"Aging and Disease"},{"key":"10.1016\/bs.irn.2026.07.003_bib61","first-page":"1","article-title":"Pre-symptomatic Parkinson\u2019s disease blood test quantifying repetitive sequence motifs in transfer RNA fragments","author":"Madrer","year":"2025","journal-title":"Nature Aging"},{"key":"10.1016\/bs.irn.2026.07.003_bib62","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.parkreldis.2019.05.035","article-title":"TRNA-derived fragments as sex-dependent circulating candidate biomarkers for Parkinson\u2019s disease","volume":"65","author":"Magee","year":"2019","journal-title":"Parkinsonism & Related Disorders"},{"issue":"1","key":"10.1016\/bs.irn.2026.07.003_bib63","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/s41531-022-00288-w","article-title":"Multi-modality machine learning predicting Parkinson\u2019s disease","volume":"8","author":"Makarious","year":"2022","journal-title":"Npj Parkinson\u2019s Disease"},{"issue":"10","key":"10.1016\/bs.irn.2026.07.003_bib64","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.biopsych.2015.04.005","article-title":"Brain glutathione levels\u2013a novel biomarker for mild cognitive impairment and Alzheimer\u2019s disease","volume":"78","author":"Mandal","year":"2015","journal-title":"Biological Psychiatry"},{"issue":"1","key":"10.1016\/bs.irn.2026.07.003_bib65","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.bbrc.2011.11.047","article-title":"Brain oxidative stress: Detection and mapping of anti-oxidant marker \u2018Glutathione\u2019\u00a0in different brain regions of healthy male\/female, MCI and Alzheimer patients using non-invasive magnetic resonance spectroscopy","volume":"417","author":"Mandal","year":"2012","journal-title":"Biochemical and Biophysical Research Communications"},{"issue":"4","key":"10.1016\/bs.irn.2026.07.003_bib66","doi-asserted-by":"crossref","first-page":"943","DOI":"10.3390\/nu15040943","article-title":"ATP and NAD+ deficiency in Parkinson\u2019s disease","volume":"15","author":"Mischley","year":"2023","journal-title":"Nutrients"},{"key":"10.1016\/bs.irn.2026.07.003_bib67","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2021.617588","article-title":"Mitochondrial dysfunction and oxidative stress in Alzheimer\u2019s disease","volume":"13","author":"Misrani","year":"2021","journal-title":"Frontiers in Aging Neuroscience"},{"issue":"6","key":"10.1016\/bs.irn.2026.07.003_bib68","doi-asserted-by":"crossref","first-page":"6785","DOI":"10.1007\/s12035-024-04468-y","article-title":"Exploring the mechanisms and therapeutic approaches of mitochondrial dysfunction in Alzheimer\u2019s disease: An educational literature review","volume":"62","author":"Moawad","year":"2025","journal-title":"Molecular Neurobiology"},{"issue":"1","key":"10.1016\/bs.irn.2026.07.003_bib69","doi-asserted-by":"crossref","first-page":"12129","DOI":"10.1038\/s41598-025-96950-3","article-title":"Voice biomarkers as prognostic indicators for Parkinson\u2019s disease using machine learning techniques","volume":"15","author":"Naeem","year":"2025","journal-title":"Scientific Reports"},{"issue":"2","key":"10.1016\/bs.irn.2026.07.003_bib70","doi-asserted-by":"crossref","first-page":"114","DOI":"10.3390\/toxics13020114","article-title":"Epigenetic biomarkers driven by environmental toxins associated with Alzheimer\u2019s disease, Parkinson\u2019s disease, and amyotrophic lateral sclerosis in the United States: A systematic review","volume":"13","author":"Newell","year":"2025","journal-title":"Toxics"},{"issue":"4","key":"10.1016\/bs.irn.2026.07.003_bib71","doi-asserted-by":"crossref","first-page":"340","DOI":"10.3390\/cells13040340","article-title":"Salivary biomarkers for parkinson\u2019s disease: A systematic review with meta-analysis","volume":"13","author":"Nijakowski","year":"2024","journal-title":"Cells"},{"key":"10.1016\/bs.irn.2026.07.003_bib72","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.freeradbiomed.2024.03.017","article-title":"Mitochondria-tau association promotes cognitive decline and hippocampal bioenergetic deficits during the aging","volume":"217","author":"Olesen","year":"2024","journal-title":"Free Radical Biology and Medicine"},{"issue":"24","key":"10.1016\/bs.irn.2026.07.003_bib73","doi-asserted-by":"crossref","first-page":"6464","DOI":"10.1039\/D3MA00623A","article-title":"Advances in graphene-based nanoplatforms and their application in Parkinson\u2019s disease","volume":"4","author":"Oz","year":"2023","journal-title":"Materials Advances"},{"issue":"18","key":"10.1016\/bs.irn.2026.07.003_bib74","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1016\/j.cub.2015.07.050","article-title":"Elevated mitochondrial bioenergetics and axonal arborization size are key contributors to the vulnerability of dopamine neurons","volume":"25","author":"Pacelli","year":"2015","journal-title":"Current Biology"},{"issue":"1","key":"10.1016\/bs.irn.2026.07.003_bib75","article-title":"Amyloid\u2010beta interaction with mitochondria","volume":"2011","author":"Pagani","year":"2011","journal-title":"International Journal of Alzheimer\u2019s Disease"},{"key":"10.1016\/bs.irn.2026.07.003_bib76","doi-asserted-by":"crossref","DOI":"10.1016\/j.neumar.2025.100037","article-title":"Values of epigenetic markers in Parkinson\u2019s disease as biomarkers and therapeutic targets: A narrative review","author":"Parikh","year":"2025","journal-title":"NeuroMarkers"},{"key":"10.1016\/bs.irn.2026.07.003_bib77","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2025.1530240","article-title":"Implications of heart rate variability measured using wearable electrocardiogram devices in diagnosing Parkinson\u2019s disease and its association with neuroimaging biomarkers: A case-control study","volume":"17","author":"Park","year":"2025","journal-title":"Frontiers in Aging Neuroscience"},{"key":"10.1016\/bs.irn.2026.07.003_bib78","doi-asserted-by":"crossref","first-page":"53","DOI":"10.3389\/fnagi.2014.00053","article-title":"Differential role of CSF alpha-synuclein species, tau, and A\u03b242 in Parkinson\u2019s Disease","volume":"6","author":"Parnetti","year":"2014","journal-title":"Frontiers in Aging Neuroscience"},{"key":"10.1016\/bs.irn.2026.07.003_bib79","doi-asserted-by":"crossref","DOI":"10.1016\/j.parkreldis.2024.107240","article-title":"A systematic review of biofluid phosphorylated \u03b1-synuclein in Parkinson\u2019s disease","volume":"132","author":"Pedersen","year":"2025","journal-title":"Parkinsonism & Related Disorders"},{"issue":"3","key":"10.1016\/bs.irn.2026.07.003_bib80","article-title":"Mitochondrial dysfunction in Alzheimer\u2019s disease: Guiding the path to targeted therapies","volume":"22","author":"Percy","year":"2025","journal-title":"Neurotherapeutics"},{"issue":"18","key":"10.1016\/bs.irn.2026.07.003_bib81","doi-asserted-by":"crossref","first-page":"3489","DOI":"10.1111\/bph.14585","article-title":"Mitochondrial dysfunction in Alzheimer\u2019s disease: Role in pathogenesis and novel therapeutic opportunities","volume":"176","author":"Perez Ortiz","year":"2019","journal-title":"British Journal of Pharmacology"},{"issue":"3","key":"10.1016\/bs.irn.2026.07.003_bib82","doi-asserted-by":"crossref","first-page":"534","DOI":"10.4103\/1673-5374.320972","article-title":"Circulating extracellular vesicles: Friends and foes in neurodegeneration","volume":"17","author":"Picca","year":"2022","journal-title":"Neural Regeneration Research"},{"issue":"2","key":"10.1016\/bs.irn.2026.07.003_bib83","doi-asserted-by":"crossref","first-page":"504","DOI":"10.3390\/jcm9020504","article-title":"Mitochondrial signatures in circulating extracellular vesicles of older adults with Parkinson\u2019s disease: Results from the EXosomes in PArkiNson\u2019s disease (EXPAND) study","volume":"9","author":"Picca","year":"2020","journal-title":"Journal of Clinical Medicine"},{"issue":"5","key":"10.1016\/bs.irn.2026.07.003_bib84","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1002\/ana.23955","article-title":"Low cerebrospinal fluid concentration of mitochondrial DNA in preclinical Alzheimer disease","volume":"74","author":"Podlesniy","year":"2013","journal-title":"Annals of Neurology"},{"key":"10.1016\/bs.irn.2026.07.003_bib85","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2023.137596","article-title":"Fingolimod exerts neuroprotection by regulating S1PR1 mediated BNIP3-PINK1-Parkin dependent mitophagy in rotenone induced mouse model of Parkinson\u2019s disease","volume":"820","author":"Rajan","year":"2024","journal-title":"Neuroscience Letters"},{"issue":"5","key":"10.1016\/bs.irn.2026.07.003_bib86","doi-asserted-by":"crossref","first-page":"488","DOI":"10.3390\/cells8050488","article-title":"Amyloid beta and phosphorylated tau-induced defective autophagy and mitophagy in Alzheimer\u2019s disease","volume":"8","author":"Reddy","year":"2019","journal-title":"Cells"},{"key":"10.1016\/bs.irn.2026.07.003_bib87","series-title":"Nanomedical Drug Delivery for Neurodegenerative Diseases","first-page":"1","article-title":"Aetiology and pathophysiology of neurodegenerative disorders","author":"Sahoo","year":"2022"},{"issue":"5","key":"10.1016\/bs.irn.2026.07.003_bib88","doi-asserted-by":"crossref","first-page":"325","DOI":"10.5607\/en20042","article-title":"Urinary biomarkers for neurodegenerative diseases","volume":"29","author":"Seol","year":"2020","journal-title":"Experimental Neurobiology"},{"issue":"24","key":"10.1016\/bs.irn.2026.07.003_bib89","doi-asserted-by":"crossref","first-page":"4383","DOI":"10.1021\/acschemneuro.3c00717","article-title":"Glutathione depletion and concomitant elevation of susceptibility in patients with parkinson\u2019s disease: State-of-the-art MR spectroscopy and neuropsychological study","volume":"14","author":"Shukla","year":"2023","journal-title":"ACS Chemical Neuroscience"},{"issue":"1","key":"10.1016\/bs.irn.2026.07.003_bib90","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1002\/hbm.24799","article-title":"Quantitation of in vivo brain glutathione conformers in cingulate cortex among age\u2010matched control, MCI, and AD patients using MEGA\u2010PRESS","volume":"41","author":"Shukla","year":"2020","journal-title":"Human Brain Mapping"},{"issue":"6","key":"10.1016\/bs.irn.2026.07.003_bib91","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0099897","article-title":"Repair of oxidative DNA damage, cell-cycle regulation and neuronal death may influence the clinical manifestation of Alzheimer\u2019s disease","volume":"9","author":"Silva","year":"2014","journal-title":"PloS One"},{"key":"10.1016\/bs.irn.2026.07.003_bib92","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2147\/DNND.S361526","article-title":"Mitochondrial toxicant-induced neuronal apoptosis in Parkinson\u2019s disease: What we know so far","volume":"13","author":"Sivagurunathan","year":"2023","journal-title":"Degenerative Neurological and Neuromuscular Disease"},{"issue":"1","key":"10.1016\/bs.irn.2026.07.003_bib93","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1038\/s41746-024-01217-2","article-title":"Digital biomarkers for precision diagnosis and monitoring in Parkinson\u2019s disease","volume":"7","author":"Sun","year":"2024","journal-title":"NPJ Digital Medicine"},{"issue":"2","key":"10.1016\/bs.irn.2026.07.003_bib94","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nrn.2016.178","article-title":"Selective neuronal vulnerability in Parkinson disease","volume":"18","author":"Surmeier","year":"2017","journal-title":"Nature Reviews Neuroscience"},{"issue":"1","key":"10.1016\/bs.irn.2026.07.003_bib95","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/S1474-4422(21)00361-6","article-title":"Blood-based biomarkers for Alzheimer\u2019s disease: Towards clinical implementation","volume":"21","author":"Teunissen","year":"2022","journal-title":"The Lancet Neurology"},{"key":"10.1016\/bs.irn.2026.07.003_bib96","series-title":"Alzheimer\u2019s disease","first-page":"1","article-title":"Understanding Alzheimer\u2019s disease: An introduction, pathophysiology, and diagnosis","author":"Tripathi","year":"2026"},{"key":"10.1016\/bs.irn.2026.07.003_bib97","article-title":"Mitochondrial dysfunction and oxidative stress in Parkinson\u2019s disease: Mechanisms, biomarkers, and therapeutic strategies","author":"Usha Kiran","year":"2025","journal-title":"Tissue Barriers"},{"issue":"15","key":"10.1016\/bs.irn.2026.07.003_bib98","doi-asserted-by":"crossref","first-page":"2756","DOI":"10.1021\/acschemneuro.5c00313","article-title":"Exosomes and their miRNA as a potential biomarker in the diagnosis of Parkinson\u2019s disease","volume":"16","author":"Vijayakumar","year":"2025","journal-title":"ACS Chemical Neuroscience"},{"issue":"3\u20134","key":"10.1016\/bs.irn.2026.07.003_bib99","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.drudis.2012.09.001","article-title":"Biomarkers of Parkinson\u2019s disease: Current status and future perspectives","volume":"18","author":"Wang","year":"2013","journal-title":"Drug Discovery Today"},{"issue":"8","key":"10.1016\/bs.irn.2026.07.003_bib100","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1016\/j.bbadis.2013.10.015","article-title":"Oxidative stress and mitochondrial dysfunction in Alzheimer\u2019s disease","volume":"1842","author":"Wang","year":"2014","journal-title":"Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease"},{"issue":"9","key":"10.1016\/bs.irn.2026.07.003_bib101","doi-asserted-by":"crossref","first-page":"5273","DOI":"10.1007\/s10787-025-01916-6","article-title":"Bioenergetic failure and oxidative stress: Mitochondrial contributions to Alzheimer\u2019s disease: R. Wasim et al","volume":"33","author":"Wasim","year":"2025","journal-title":"Inflammopharmacology"},{"key":"10.1016\/bs.irn.2026.07.003_bib102","doi-asserted-by":"crossref","first-page":"236","DOI":"10.3389\/fnmol.2018.00236","article-title":"Oxidative stress in Parkinson\u2019s disease: A systematic review and meta-analysis","volume":"11","author":"Wei","year":"2018","journal-title":"Frontiers in Molecular Neuroscience"},{"issue":"11","key":"10.1016\/bs.irn.2026.07.003_bib103","doi-asserted-by":"crossref","first-page":"7607","DOI":"10.21037\/qims-23-509","article-title":"Ultra-high-field 7T MRI in Parkinson\u2019s disease: Ready for clinical use?\u2014a narrative review","volume":"13","author":"Welton","year":"2023","journal-title":"Quantitative Imaging in Medicine and Surgery"},{"key":"10.1016\/bs.irn.2026.07.003_bib104","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2025.1586273","article-title":"Non-invasive detection of Parkinson\u2019s disease based on speech analysis and interpretable machine learning","volume":"17","author":"Xu","year":"2025","journal-title":"Frontiers in Aging Neuroscience"},{"issue":"1","key":"10.1016\/bs.irn.2026.07.003_bib105","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/4505720","article-title":"Differential expression of mRNAs in peripheral blood related to prodrome and progression of Alzheimer\u2019s disease","volume":"2020","author":"Xue","year":"2020","journal-title":"BioMed Research International"},{"key":"10.1016\/bs.irn.2026.07.003_bib106","doi-asserted-by":"crossref","DOI":"10.1177\/20552076251342457","article-title":"Nanobiosensors in neurodegenerative disease diagnosis: A promising pathway for early detection","volume":"11","author":"Yadav","year":"2025","journal-title":"Digital Health"},{"issue":"s2","key":"10.1016\/bs.irn.2026.07.003_bib107","doi-asserted-by":"crossref","first-page":"S299","DOI":"10.3233\/JAD-230314","article-title":"Mitochondria-related candidate genes and diagnostic model to predict late-onset Alzheimer\u2019s disease and mild cognitive impairment","volume":"99","author":"Yan","year":"2024","journal-title":"Journal of Alzheimer\u2019s Disease"},{"issue":"10","key":"10.1016\/bs.irn.2026.07.003_bib108","doi-asserted-by":"crossref","first-page":"2616","DOI":"10.1111\/ejn.16296","article-title":"Neuromelanin\u2010sensitive magnetic resonance imaging: Possibilities and promises as an imaging biomarker for Parkinson\u2019s disease","volume":"59","author":"Yan","year":"2024","journal-title":"European Journal of Neuroscience"},{"issue":"6","key":"10.1016\/bs.irn.2026.07.003_bib109","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1111\/cts.13508","article-title":"Associations of striatal dopamine transporter binding with motor and non\u2010motor symptoms in early Parkinson\u2019s disease","volume":"16","author":"Yang","year":"2023","journal-title":"Clinical and Translational Science"},{"issue":"1","key":"10.1016\/bs.irn.2026.07.003_bib110","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s13064-025-00223-8","article-title":"A review of mitochondrial dysfunction, pathophysiology and therapeutic prospects in neurodegenerative diseases","volume":"20","author":"Yusuf","year":"2025","journal-title":"Discover Neuroscience"},{"issue":"1","key":"10.1016\/bs.irn.2026.07.003_bib111","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s13041-025-01200-2","article-title":"Target oxidative stress-induced disulfidptosis: Novel therapeutic avenues in Parkinson\u2019s disease","volume":"18","author":"Zhang","year":"2025","journal-title":"Molecular Brain"},{"issue":"1","key":"10.1016\/bs.irn.2026.07.003_bib112","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1038\/s41531-025-01134-5","article-title":"Synergistic blood-based diagnostic value of AP3B1 and BMPR2 in Parkinson\u2019s disease","volume":"11","author":"Zhao","year":"2025","journal-title":"Npj Parkinson\u2019s Disease"},{"issue":"s1","key":"10.1016\/bs.irn.2026.07.003_bib113","doi-asserted-by":"crossref","first-page":"S183","DOI":"10.3233\/JPD-223277","article-title":"Blood and cerebrospinal fluid biomarkers of inflammation in Parkinson\u2019s disease","volume":"12","author":"Zimmermann","year":"2022","journal-title":"Journal of Parkinson\u2019s Disease"},{"key":"10.1016\/bs.irn.2026.07.003_bib114","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.parkreldis.2022.06.001","article-title":"Plasma and serum alpha-synuclein as a biomarker in Parkinson\u2019s disease: A meta-analysis","volume":"99","author":"Zubelzu","year":"2022","journal-title":"Parkinsonism & Related Disorders"}],"container-title":["International Review of Neurobiology","Blood-Based Biomarkers for Alzheimers and Parkinsons Disease - Part A"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0074774226000796?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0074774226000796?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T16:22:24Z","timestamp":1790266944000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0074774226000796"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"ISBN":["9780443472169"],"references-count":114,"URL":"https:\/\/doi.org\/10.1016\/bs.irn.2026.07.003","relation":{},"ISSN":["0074-7742"],"issn-type":[{"value":"0074-7742","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]}}}